3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Colorectal Neoplasms
8
Breast Neoplasms
7
Polycythemia Vera
5
Venous Thromboembolism
3
Melanoma
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Tobacco Use Disorder
2
Thrombocythemia, Essential
2
Smoking Cessation
2
Rectal Neoplasms
2
Prostatic Neoplasms
2
Neoplastic Cells, Circulating
2
Neoplasms
2
Neoplasm Metastasis
2
Myeloproliferative Disorders
2
Multiple Myeloma
2
Lung Neoplasms
2
Barrett Esophagus
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Tuberous Sclerosis
1
Thromboembolism
1
Testicular Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Seizures
1
Salivary Gland Neoplasms
1
Recurrence
1
Primary Myelofibrosis
1
Precancerous Conditions
1
Interventions
Cisplatin
68
Paclitaxel
32
Radiotherapy
31
Carboplatin
23
Bevacizumab
21
pembrolizumab
20
Brachytherapy
18
atezolizumab
11
camrelizumab
10
Nivolumab
10
Gemcitabine
10
Drug Therapy
9
tislelizumab
8
Topotecan
8
Taxes
8
Chemoradiotherapy
8
Radiation
7
Docetaxel
7
Albumin-Bound Paclitaxel
7
zimberelimab
6
toripalimab
6
nimotuzumab
6
Magnetic Resonance Spectroscopy
6
Cetuximab
6
lenvatinib
5
durvalumab
5
dostarlimab
5
Platinum
5
Papillomavirus Vaccines
5
Injections
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Uterine Cervical Neoplasms
×
Aspirin
×
Clear all
NCT03192059
2021-09-08
PRIMMO
University Hospital, Ghent
Phase 2
Completed
43 enrolled